John T. Soper

Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

Andrew Berchuck, Ayman H. Kamel, Regina S. Whitaker et al. · PubMed · 1990 · 765 citations

Breast Oncology, Oncology, Medicine +14

Oral Medroxyprogesterone Acetate in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Dose-Response Study by the Gynecologic Oncology Group

J.T. Thigpen, Mark F. Brady, Ronald D. Alvarez et al. · Journal of Clinical Oncology · 1999 · 478 citations

Recurrent Endometrial Carcinoma, Endocrine Oncology, Endocrine-related Cancer +14

Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

Janiel M. Cragun, Laura J. Havrilesky, Brian Calingaert et al. · Journal of Clinical Oncology · 2005 · 444 citations

Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody.

Debra A. Budwit-Novotny, Kenneth S. McCarty, Edwin B. Cox et al. · PubMed · 1986 · 388 citations

Endometrial Adenocarcinoma, Hormonal Receptor, Uterine Receptivity +11

A Phase III Trial of Ifosfamide with or without Cisplatin in Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

Gregory P. Sutton, Virginia L. Brunetto, Larry C. Kilgore et al. · Gynecologic Oncology · 2000 · 257 citations

Medicine, Phase Iii Trial, Gynecology +6